Transplant diagnostics: Key market research findings
- Immense growth potential in emerging markets
- Kidney transplantation segment accounts for the majority share of the market revenue
- Key vendors—Bio-Rad Laboratories, CareDx, Illumina, Immucor, Linkage Biosciences, and ThermoFisher
Technavio’s market research analysts estimate the global transplant diagnostics market to grow at a CAGR of more than 6% between 2016 and 2020. The increase in public awareness brought about by initiatives taken by governmental and non-governmental institutions about organ transplant is the primary driver for the market. The market is projected to benefit from the increasing opportunities in emerging markets such as India, China, Russia, Argentina, Brazil, Mexico, the Czech Republic, and Poland during the forecast period. In 2015, the Americas dominated the global transplant diagnostics market by accounting for over 52% of the total market share. The high perseverance of chronic diseases and the increasing number of mergers and acquisitions amongst various vendors are factors that will contribute to growth in the market during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of the transplant diagnostics segments by application.
“Of late, the vendors in the market are launching new products due to the growing demand and use of transplant diagnostics. Many of these new products are being approved by the Food and Drug Administration (FDA) and hence, are becoming more accessible to medical personnel and individuals. For instance, CareDx launched AlloMap, a blood-based molecular test monitoring organ rejection after the transplantation process, that can significantly reduce the cost of post-transplant process,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
In 2015, the kidney transplantation segment was the major revenue contributor by accounting for almost 51% of the overall market share. This segment of the market is thriving to the higher significant potential of kidney post-transplant as opposed to other organ post-transplant diagnostics. Private-public funding for the development of human leukocyte antigen (HLA) typing technology and solid organ-based transplantation are factors that will further fuel the growth of the kidney transplantation market across the globe by 2020.
The key vendors in the global transplant diagnostics market include Bio-Rad Laboratories, CareDx, Illumina, Immucor, Linkage Biosciences, and ThermoFisher. The market has the presence of many global and local providers who are implementing various strategies to gain a competitive edge over their peers. The established vendors have greater brand recognition, financial and technical resource, and product development and marketing capabilities, which has intensified the competition in the market. Several vendors are shifting their operations to APAC owing to the huge growth opportunities in the region. Also, vendors are developing their relationship with transplant centers and hospitals to gain maximum market reach.
A more detailed analysis is available in the Technavio report, Global Transplant Diagnostics Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
